Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corporation (NYSE: DDD) generates a steady flow of news across healthcare, aerospace and defense, industrial manufacturing, software and capital markets. As a pioneer in additive manufacturing, the company regularly issues updates on new 3D printers, materials, software platforms and application-specific solutions, as well as regulatory milestones and strategic partnerships.
Recent announcements highlight growth initiatives in aerospace and defense, where 3D Systems reports strong momentum in production printing systems and custom metal parts, expansion of its Littleton, Colorado A&D Application Center of Excellence, and participation in U.S. Air Force–sponsored programs for next-generation metal printing technologies. The company also shares developments from its NAMI joint venture in Saudi Arabia, including agreements in energy, infrastructure inspection and collaborations with major defense contractors.
In healthcare, news items include FDA 510(k) clearance expanding indications for the VSP Orthopedics virtual surgical planning platform to skeletally mature adolescents, along with commentary on the role of personalized healthcare and patient-specific devices in the company’s Med Tech business. Product-focused releases cover new stereolithography solutions such as the SLA 825 Dual, investment casting tools like ArrayCast and Accura SbF, and jewelry-focused systems such as the MJP 300W Plus wax printer.
Investors will also find financial and corporate updates, including quarterly earnings releases, software strategy announcements involving 3D Sprint, Oqton MOS and 3DXpert, and transactions related to convertible notes and capital structure. This news page brings together these diverse updates so readers can follow how 3D Systems’ technologies, partnerships and financial decisions shape its role in additive manufacturing.
Volumetric, a Houston-based biofabrication start-up, has been acquired by 3D Systems (NYSE: DDD) for an initial payment of
3D Systems has announced the acquisition of Volumetric Biotechnologies for an initial payment of $45 million, with a potential total value of $400 million tied to future performance milestones. This acquisition aims to enhance 3D Systems’ capabilities in the bioprinting of human organs, particularly focusing on the liver and other applications. Dr. Jordan Miller will join as Chief Scientist for Regenerative Medicine to lead this initiative, expanding the company's efforts alongside United Therapeutics in creating vital organ solutions. A conference call on October 28, 2021, will provide further details.
3D Systems (DDD) announced that it will release its third quarter 2021 financial results and file its Form 10-Q on November 8, 2021, after U.S. markets close. A conference call to discuss these results will take place on November 9, 2021, at 8:30 a.m. ET. Investors can participate via telephone or webcast. The company emphasizes its reliance on forward-looking statements, cautioning that actual results may differ due to various risks and uncertainties. More details can be found on their investor relations webpage.
Trilantic North America has acquired the On-Demand Manufacturing business from 3D Systems (NYSE: DDD), rebranding it as Quickparts. This strategic move is led by industry veteran Ziad Abou, who becomes CEO. Quickparts, recognized in digital manufacturing, aims to expand its services and enhance customer value with over 150 in-house 3D printers across North America and Europe. The acquisition highlights Trilantic's commitment to advancing Industry 4.0 technologies and better serving diverse markets.
3D Systems (NYSE: DDD) has launched VisiJet Wax Jewel Red, a new material designed for jewelry casting that enhances design capabilities and production efficiency. This innovative material allows for more intricate designs, improved durability, and flexibility, addressing the needs of casting houses. It enables same-day pattern printing and casting while reducing waste and operational costs. Planned availability is on September 20, 2021, marking a significant advancement in the 3D printing landscape for jewelry manufacturing.
3D Systems (NYSE: DDD) announces its acquisition of Oqton, a leader in cloud-based Manufacturing Operating Systems (MOS). The $180 million deal aims to enhance digital manufacturing through AI and automation, addressing the growing demand for advanced manufacturing technologies. Operating independently, Oqton will ensure data security for customers. The acquisition is expected to accelerate software revenue, projecting over $100 million by 2025. The deal is anticipated to close in Q4 2021, pending regulatory approvals.
3D Systems has announced Dr. Brent Stucker as the new Chief Scientist to enhance its leadership in additive manufacturing. Previously, he was the Director of Additive Manufacturing at Ansys and co-founded 3DSIM, a pioneer in AM simulation. Dr. Stucker, known for his extensive publications and contributions to industry standards, is set to drive innovation at 3D Systems. CEO Dr. Jeffrey Graves emphasized Stucker's unique qualifications to help meet customer needs and advance the entire additive industry.
3D Systems (NYSE: DDD) has expanded its materials portfolio by introducing Certified Scalmalloy and Certified M789, enhancing its Direct Metal Printing (DMP) capabilities. Scalmalloy features a tensile strength of 520MPa, ideal for aerospace and automotive applications, while M789 offers high-strength molds free of cobalt, certified for DMP. These innovations support faster time to market and improved manufacturing efficiency across various industries including aerospace, motorsports, and energy. Customers can leverage the Application Innovation Group's expertise to certify these materials effectively.
3D Systems Corporation (NYSE:DDD) reported strong Q2 2021 results, with revenue of $162.6 million, marking a 44.1% increase year-over-year. Adjusted EBITDA margin improved to 12.4%, and the company achieved a positive operating cash flow of $13.5 million. The growth was driven by a 68.6% rise in Healthcare revenue and 25.3% in Industrial sales. After divestitures, the balance sheet is set to improve, with cash projected to exceed $500 million. Despite a GAAP loss of $0.08 per share, the company remains optimistic about its growth trajectory and strategic focus on additive manufacturing.
3D Systems has announced the sale of its medical simulation business, Simbionix, to Surgical Science Sweden AB for $305 million. This divestiture is part of 3D Systems' strategy to focus exclusively on additive manufacturing. Following the transaction, 3D Systems will hold approximately $500 million in cash and have no debt. The company aims for growth and margin expansion in the additive manufacturing sector, emphasizing its industry-leading technology and operational efficiency. The completion of the transaction is expected in August 2021, with Simbionix reported sales of $40.8 million in 2020.